A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease
Clinical trial NCT05587322 · COMPLETED
Trial details
- NCT number
- NCT05587322
- Sponsor
- Braintree Laboratories
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-06
- Primary completion
- 2023-10-13
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.